New publications in health economics and genomics 6th April 2021

Two publications from the past week:

  • Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment | link
  • Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 30th March 2021

Three publications from the past week:

  • Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review | link
  • Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights | link
  • Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd March 2021

Four publications from the past week:

  • Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement | link
  • Cost of whole genome sequencing for non-typhoidal Salmonella enterica | link
  • Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation | link
  • Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th March 2021

Two publications from the past week:

  • Comprehensive Genomic Profiling for Non-Small-Cell Lung Cancer: Health and Budget Impact | link
  • The ethics of resource allocation in translational genomic medicine | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 9th March 2021

Three publications from the past week:

  • Economic evaluation of whole genome sequencing for pathogen identification and surveillance – results of case studies in Europe and the Americas 2016 to 2019 | link
  • Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study | link
  • Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd February 2021

One publication from the past week:

  • Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th February 2021

Two publications from the past week:

  • Availability and funding of clinical genomic sequencing globally | link
  • Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 9th February 2021

Three publications from the past week:

  • Value and affordability in precision medicine | link
  • Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases | link
  • Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 26th January 2021

One publication from the past week:

  • Real-world utilization of biomarker testing for patients with advanced non-small-cell lung cancer in a tertiary referral center and referring hospitals | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 19th January 2021

Two publications from the past week:

  • Valuing genetic and genomic testing in France: current challenges and latest evidence | link
  • The ethics of genomic medicine: redefining values and norms in the UK and France | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.